Drospirenone-EE 3-0.02 MG tab 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FM0BN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,140
Award facts
- Contract value 100% obligated
- $1,140.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in a 28-count package, with a ceiling value of $1,140.05. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery order for Drospirenone-EE tablets reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through the DLA's global pharmaceutical supply chain, which is designed to provide flexible and comprehensive medical commodity support to defense customers worldwide.
Quick answers
Who was awarded contract SPE2DR26FM0BN?
SPE2DR26FM0BN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FM0BN worth?
The government has obligated $1,140 on SPE2DR26FM0BN.
Is contract SPE2DR26FM0BN an order under another contract?
Yes. SPE2DR26FM0BN is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0BN competed?
The extent of competition for SPE2DR26FM0BN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award